Literature DB >> 26718942

Faecal microbiome in new-onset juvenile idiopathic arthritis.

M V Tejesvi1, M Arvonen2,3,4,5, S M Kangas6,7,8,9, P L Keskitalo6,7,8, A M Pirttilä1, T J Karttunen8,10,11, P Vähäsalo6,7,8.   

Abstract

Alterations in the intestinal microbial flora have been linked with autoimmune diseases. Our objective was to analyse the composition of the faecal microbiome of children with new-onset juvenile idiopathic arthritis (JIA) compared to healthy controls, and to identify specific gut bacteria associated with JIA. Stool samples from patients were taken at the time of diagnosis of JIA. The microbiome profiles of samples of 30 children with JIA (mean age 6.2 years, 22 girls) were analysed with 16S region-based sequencing profiling and compared to the stool samples of healthy controls (n = 27, mean age 5.4 years, 18 girls). The proportion of bacteria belonging to the phylum Firmicutes was significantly lower in children with JIA [21 % (95 % confident interval [CI]: 17-25 %)] compared to controls [33 % (95 % CI: 26-41 %), p = 0.009]. Bacteria belonging to Bacteroidetes were significantly more abundant in JIA [78 % (95 % CI: 74-82 %)] than in control samples [65 % (95 % CI: 57-73 %), p = 0.008]. Shared operational taxonomic units (OTUs) between the groups revealed that genera Actinobacteria and Fusobacteria were present only in JIA patients and Lentisphaerae only in controls. In summary, faecal flora in JIA is characterised by a low level of Firmicutes and an abundance of Bacteroidetes, resembling the aberration reported in type 1 diabetes. We suggest that alterations in the intestinal microbial flora may challenge the mucosal immune system of genetically susceptible subjects predisposing to local proinflammatory cascades, thus contributing to the development of JIA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26718942     DOI: 10.1007/s10096-015-2548-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  41 in total

1.  Microbial exposure during early life has persistent effects on natural killer T cell function.

Authors:  Torsten Olszak; Dingding An; Sebastian Zeissig; Miguel Pinilla Vera; Julia Richter; Andre Franke; Jonathan N Glickman; Reiner Siebert; Rebecca M Baron; Dennis L Kasper; Richard S Blumberg
Journal:  Science       Date:  2012-03-22       Impact factor: 47.728

2.  Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis.

Authors:  Elnaz Vaghef-Mehrabany; Beitullah Alipour; Aziz Homayouni-Rad; Sakineh-Khatoon Sharif; Mohammad Asghari-Jafarabadi; Sema Zavvari
Journal:  Nutrition       Date:  2013-12-17       Impact factor: 4.008

3.  Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters.

Authors:  P Picco; M Gattorno; N Marchese; S Vignola; M P Sormani; A Barabino; A Buoncompagni
Journal:  Clin Exp Rheumatol       Date:  2000 Nov-Dec       Impact factor: 4.473

4.  Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis.

Authors:  Mary-Ellen Costello; Francesco Ciccia; Dana Willner; Nicole Warrington; Philip C Robinson; Brooke Gardiner; Mhairi Marshall; Tony J Kenna; Giovanni Triolo; Matthew A Brown
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

5.  Fecal microbiota in early rheumatoid arthritis.

Authors:  Jussi Vaahtovuo; Eveliina Munukka; Mika Korkeamäki; Reijo Luukkainen; Paavo Toivanen
Journal:  J Rheumatol       Date:  2008-06-01       Impact factor: 4.666

6.  Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis.

Authors:  M Arvonen; P Vähäsalo; S Turunen; H M Salo; M Mäki; K Laurila; O Vaarala; T J Karttunen
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

7.  Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.

Authors:  Rebeca Martín; Florian Chain; Sylvie Miquel; Jane M Natividad; Harry Sokol; Elena F Verdu; Philippe Langella; Luis G Bermúdez-Humarán
Journal:  Hum Vaccin Immunother       Date:  2014-04-14       Impact factor: 3.452

8.  Dietary heme alters microbiota and mucosa of mouse colon without functional changes in host-microbe cross-talk.

Authors:  Noortje IJssennagger; Muriel Derrien; Gerdien M van Doorn; Anneke Rijnierse; Bartholomeus van den Bogert; Michael Müller; Jan Dekker; Michiel Kleerebezem; Roelof van der Meer
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

9.  Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes.

Authors:  Christopher T Brown; Austin G Davis-Richardson; Adriana Giongo; Kelsey A Gano; David B Crabb; Nabanita Mukherjee; George Casella; Jennifer C Drew; Jorma Ilonen; Mikael Knip; Heikki Hyöty; Riitta Veijola; Tuula Simell; Olli Simell; Josef Neu; Clive H Wasserfall; Desmond Schatz; Mark A Atkinson; Eric W Triplett
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

10.  Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis.

Authors:  Jose U Scher; Andrew Sczesnak; Randy S Longman; Nicola Segata; Carles Ubeda; Craig Bielski; Tim Rostron; Vincenzo Cerundolo; Eric G Pamer; Steven B Abramson; Curtis Huttenhower; Dan R Littman
Journal:  Elife       Date:  2013-11-05       Impact factor: 8.140

View more
  26 in total

1.  Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis.

Authors:  Lampros Fotis; Nurmohammad Shaikh; Kevin W Baszis; Charles M Samson; Raffi Lev-Tzion; Anthony R French; Phillip I Tarr
Journal:  J Rheumatol       Date:  2017-09-15       Impact factor: 4.666

2.  Gut microbiome in children with enthesitis-related arthritis in a developing country and the effect of probiotic administration.

Authors:  A Aggarwal; A N Sarangi; P Gaur; A Shukla; R Aggarwal
Journal:  Clin Exp Immunol       Date:  2016-12-12       Impact factor: 4.330

3.  LACC1 polymorphisms in inflammatory bowel disease and juvenile idiopathic arthritis.

Authors:  G Assadi; R Saleh; F Hadizadeh; L Vesterlund; F Bonfiglio; J Halfvarson; L Törkvist; A S Eriksson; H E Harris; E Sundberg; M D'Amato
Journal:  Genes Immun       Date:  2016-04-21       Impact factor: 2.676

4.  Changes in fecal microbiota and metabolomics in a child with juvenile idiopathic arthritis (JIA) responding to two treatment periods with exclusive enteral nutrition (EEN).

Authors:  Lillemor Berntson; Peter Agback; Johan Dicksved
Journal:  Clin Rheumatol       Date:  2016-03-29       Impact factor: 2.980

Review 5.  The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

Authors:  Matthew L Stoll; Randy Q Cron
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

6.  Juvenile Idiopathic Arthritis and the Gut Microbiome: More Clues, More Questions.

Authors:  Daniel B Horton
Journal:  Arthritis Rheumatol       Date:  2019-05-06       Impact factor: 10.995

7.  The Potential of Gut Microbiota Metabolic Capability to Detect Drug Response in Rheumatoid Arthritis Patients.

Authors:  Maozhen Han; Na Zhang; Yujie Mao; Bingbing Huang; Mengfei Ren; Zhangjie Peng; Zipeng Bai; Long Chen; Yan Liu; Shanshan Wang; Shenghai Huang; Zhixiang Cheng
Journal:  Front Microbiol       Date:  2022-04-08       Impact factor: 6.064

8.  Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status.

Authors:  Monica Di Paola; Duccio Cavalieri; Davide Albanese; Maddalena Sordo; Massimo Pindo; Claudio Donati; Ilaria Pagnini; Teresa Giani; Gabriele Simonini; Alessia Paladini; Paolo Lionetti; Carlotta De Filippo; Rolando Cimaz
Journal:  Front Microbiol       Date:  2016-10-26       Impact factor: 5.640

9.  A pilot study of possible anti-inflammatory effects of the specific carbohydrate diet in children with juvenile idiopathic arthritis.

Authors:  Lillemor Berntson
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-10       Impact factor: 3.054

10.  Results from a pilot study on the oral microbiome in children and adolescents with chronic nonbacterial osteomyelitis.

Authors:  Mona Zeus; Stefan Janssen; Hans-Jürgen Laws; Ute Fischer; Arndt Borkhardt; Prasad Thomas Oommen
Journal:  Z Rheumatol       Date:  2021-07-01       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.